Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal oxytocin suppositories for pain and bleeding after elective cesarean section
IRCT20221011056143N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of oxytocin in postoperative pain and postoperative hemorrhage (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Postoperative pain reduction and Postoperative bleeding reduction. Started Oct 2022; status: completed.
02
Drugs
oxytocin
03
Conditions
postoperative painpostoperative hemorrhage
Beyond the preview
Go deeper on IRCT20221011056143N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221011056143N1.